BENGALURU: University of Oxford researchers working in vaccine development effort to prevent Covid-19 have started screening healthy volunteers (aged 18-55) for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The trial has been approved by UK regulators and ethical reviewers and interested candidates will have to volunteer for the programme. The vaccine, the university said, is based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but won’t be ready for some weeks still. “The team will enrol healthy volunteers aged between 18 – 55, who, if they pass screening, will be the first humans to test the new vaccine, called ChAdOx1 nCoV-19,” the varsity said in a statement. The trial will provide valuable information on the safety aspects of the vaccine, as well as its ability to generate an immune response against the virus. The trial — collaboration between the University’s Jenner Institute and Oxford Vaccine Group clinical teams — will recruit up to 510 volunteers. They will receive either the ChAdOx1 nCoV-19 vaccine or a control injection for comparison. “Whilst the team will start screening people now to see if they are eligible to take part in the study, participants… Read full this story
- Human trial for coronavirus vaccine starts in Queensland on 120 volunteers - and if successful it could be rolled out within months
- Russian Sovereign Fund Chief Names Three Things World Could Learn From Moscow in Tackling Covid-19
- Coronavirus latest: WHO says health workers account for 10% of global infections
- Coronavirus vaccine: Are we close to finding one? Here's what's happening
Covid-19 vaccine: Research on at Oxford lab, clinical trial on humans soon have 256 words, post on timesofindia.indiatimes.com at March 27, 2020. This is cached page on Vietnam Art News. If you want remove this page, please contact us.